LiveArena®, a Microsoft Global ISV, Launches LiveArena Broadcast Room™ – Automated Production of Corporate TV
Built entirely on Microsoft Azure and using Azure Media Services, LiveArena Broadcast is a turnkey, end-to-end service that allows any organization to produce and broadcast live and on-demand TV to any device.
The ground-breaking production solution - LiveArena Broadcast Room - based on advanced pattern recognition and AI allows for fully automated production of live TV – no production staff required.
“We are proud to extend our family of easy-to-use, yet professional, production solutions with the LiveArena Broadcast Room. Integrating LiveArena Broadcast to Microsoft Azure and Azure Media Services enabled us to provide our customers with the best in simplicity and security on a global scale. LiveArena Broadcast Room will provide the same simplicity for live event production. It is a big step towards realizing our vision of enabling any organization to have their own TV-channel,” said Anders Nilsson, CEO of LiveArena.
The advanced image detection technology supported by AI and Machine Learning used in LiveArena Broadcast Room is developed by the Dutch R&D organization TNO.
“At TNO we are excited that LiveArena, a global leader in the creation and delivery of live and on-demand corporate TV channels will integrate TNO’s Virtual Director. With this integration, LiveArena will introduce a game-changing service, enabling fully automated TV productions,” said Paul Valk, Head of TNO’s Sport and Media technology department.
To simplify the production process even further, LiveArena Broadcast Room includes a plug-in to Microsoft Office 365 as its only management interface. The plug-in enables full end-to-end control of an automated LiveArena Broadcast Room production from scheduling a live broadcast to invite viewers.
To further increase reach and accessibility of live TV-programming produced in a LiveArena Broadcast Room, the service will integrate Azure Media Services and Azure Media Analytics for offering a live speech-to-text solution and real-time translation functions that enable the on-screen subtitling of live broadcasts as well as the live translation of those subtitles into more than 80 different languages.
Sudheer Sirivara, Microsoft General Manager for Enterprise Media, said, “We are pleased that LiveArena has integrated Microsoft Azure Media Services into its platform for cloud-based web broadcasting. LiveArena’s specific use of Azure Media Services and Azure Media Analytics helps expand the availability of running live web broadcasts to a variety of market segments, supporting our mutual customers with increased audience reach, accessibility and content search functionality.”
To learn more about LiveArena Broadcast Room please visit us at IBC 2017, 14th to 19th of September, in Amsterdam in the Microsoft booth, Hall 15 (MS 1).
LiveArena Broadcast Room will be available for delivery in the first quarter of 2018.
About LiveArena
LiveArena is a global company – headquartered in Stockholm, Sweden. The company has spent more than 15 years on the cutting edge of media technology. We provide radically simple, innovative and cost-effective solutions to create and deliver live and on-demand TV-channels on any device, anywhere at any time. Our solutions are sized to fit the needs of every organization, from enterprise companies to small sports teams. Live Arena's proven solutions and services – built entirely on Microsoft Azure and Azure Media Services – manage and deliver more than 30,000 live events annually.
About TNO
TNO connects people and knowledge to create innovations that boost the competitive strength of industry and the well-being of society in a sustainable way. This is our mission and it is what drives us, the over 2,900 professionals at TNO, in our work every day. We work in collaboration with partners and focus on five transitions that we have identified together with our stakeholders.
TNO’s Sport and Media specialists research and develop applications for various market areas such as Safety & Security and Sports & Media. Customers include companies covering live events, broadcasters wishing to distribute content across multiple channels and advertisers who need to have unique content to serve their audiences. The technology is being developed by TNO experts in the field of video analysis, data science and media- end sensor data distribution. See more: www.tno.nl/sportandmedia
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170919005794/en/
Contact information
LiveArena
Pontus Eklöf
COO, LiveArena AB
+ 46 70 312 20 79
pontus.eklof@livearena.com
www.livearena.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Announces Record and Distribution Dates for Special Cash Dividend30.4.2025 09:00:00 EEST | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that a special dividend of US$55.00 per common share, as previously announced on April 1, 2025, will be paid in cash to valid holders of SINOVAC’s common shares as of the close of business on May 23, 2025, ET. Such cash dividend is expected to be paid on or about July 9, 2025. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected hand-foot-mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalificat
SES: Q1 2025 Results30.4.2025 08:30:00 EEST | Press release
SES S.A. announces financial results for the three months ended 31 March 2025. Revenue of €509 million (-0.5% yoy(1)) and Adjusted EBITDA(2) of €280 million (-0.9% yoy(1)), both growing excl. periodic impact Networks revenue up +8.4% yoy(1) including some periodic impact supported by growth in Government (+13.1% yoy(1)) and Mobility (+8.5% yoy(1)); Media (-10.6% yoy(1)) in-line with expectations €360 million of new business and contract renewals signed in Q1 2025 Net Leverage at 1.2x(3) (including cash & cash equivalents of €3.1 billion(4)) O3b mPOWER satellites 7&8 have reached final orbital position – boosting mPower network capacity and resilience from May FY 2025 financial outlook(5) on track with yoy stable Revenue and broadly stable Adjusted EBITDA re-affirmed Fully funded Intelsat acquisition anticipated to complete in H2 2025 – intention to optimise the combined debt structure On 3 April 2025, AGM approved all company recommended resolutions including prioritisation of sharehol
Geoswift Launches Visa Direct to Enhance Cross-Border Payment Offers in Over 30 Countries30.4.2025 04:00:00 EEST | Press release
Geoswift announced today the integration of Visa Direct with Geoswift's cross-border payments platform. Visa Direct facilitates payouts to more than 140 countries and territories. The integration will enable payouts in 32 countries and territories, across 13 currencies, covering major markets in Asia Pacific, North America, Europe and Middle East, with plans for more in the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423288249/en/ Bryan Ma, SVP, Head of Geoswift Global Payments, and Swapnil Mhasde, Head of Visa Direct Commercialization and Solutions, Asia Pacific, celebrating the launch in Singapore. Geoswift is a leading provider of cross-border payment services and solutions globally. With over two decades of innovation, it has become a trusted name in B2B, education, eCommerce, remittance, and travel payment use cases. Raymond Qu, Group CEO of Geoswift, stated, "At Geoswift, our vision has always been to del
Logitech Announces Q4 and Full Fiscal Year 2025 Results29.4.2025 23:03:00 EEST | Press release
SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the fourth quarter and full Fiscal Year 2025 ended March 31, 2025. For Fiscal Year 2025: Sales were $4.55 billion, up 6 percent in US dollars and 7 percent in constant currency, compared to the prior year. GAAP operating income was $655 million, up 11 percent compared to the prior year. Non-GAAP operating income was $775 million, up 11 percent compared to the prior year. GAAP earnings per share (EPS) was $4.13, up 7 percent compared to the prior year. Non-GAAP EPS was $4.84, up 14 percent compared to the prior year. Cash flow from operations was $843 million. The year-ending cash balance was $1.5 billion. The Company returned $797 million of cash to shareholders through its annual dividend payment and share repurchases. For Q4 Fiscal Year 2025: Sales were $1.01 billion, flat in US dollars and up 2 percent in constant currency, compared
U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene29.4.2025 22:32:00 EEST | Press release
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the U.S. Patent and Trademark Office (USPTO) rendered a Final Written Decision invalidating all claims of Pharmacyclics LLC’s (Pharmacyclics) U.S. Patent No. 11,672,803 (the ‘803 patent) that were challenged by BeiGene in a post-grant review (PGR) proceeding. On November 1, 2023, BeiGene filed a PGR petition with the USPTO challenging the validity of certain claims of the ‘803 patent, in response to a patent infringement lawsuit Pharmacyclics brought against BeiGene concerning BRUKINSA® (zanubrutinib). On May 1, 2024, the USPTO granted BeiGene’s petition to institute the PGR. The USPTO’s Final Written Decision is appealable by Pharmacyclics. Commenting on the ruling, BeiGene General Counsel Chan Lee said: “We are pleased that the USPTO invalidated all challenged claims of the ‘803 patent. Today’s decision reinforces our belief th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom